Metastatic hepatocellular carcinoma cured by exclusive systemic antiangiogenic therapy: Two cases along with tumor molecular profiles

Dig Liver Dis. 2021 Aug;53(8):1059-1061. doi: 10.1016/j.dld.2021.04.033. Epub 2021 May 21.
No abstract available

Keywords: Antiangiogenic; Bevacizumab; Hepato-cellular carcinoma; Investigational drugs; Sorafenib.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / therapeutic use*
  • Bevacizumab / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / genetics
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / genetics
  • Male
  • Medical Illustration
  • Sorafenib / therapeutic use*
  • Transcriptome

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab
  • Sorafenib